![Riitta Jääskeläinen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Riitta Jääskeläinen
Private Equity Investor bij Suomen Teollisuussijoitus Oy
Profiel
Riitta Jääskeläinen is currently working as an Investment Director at Suomen Teollisuussijoitus Oy since 1998.
Previously, she worked as a Director at Ipsat Therapies Oy.
Ms. Jääskeläinen completed her graduate degree in 1982 from Aalto University School of Science & Technology and in 1986 from the University of Helsinki.
Actieve functies van Riitta Jääskeläinen
Bedrijven | Functie | Begin |
---|---|---|
Suomen Teollisuussijoitus Oy
![]() Suomen Teollisuussijoitus Oy Investment ManagersFinance Suomen Teollisuussijoitus Oy (Suomen Teollisuussijoitus) is a private equity and venture capital subsidiary of Government of Finland founded in 1995. The firm is headquartered in Helsinki, Finland. | Private Equity Investor | 01-11-1998 |
Eerdere bekende functies van Riitta Jääskeläinen
Bedrijven | Functie | Einde |
---|---|---|
Ipsat Therapies Oy
![]() Ipsat Therapies Oy Pharmaceuticals: MajorHealth Technology Ipsat Therapies Oy develops and manufactures antibiotics & drugs. Its products include penicillins, cephalosporins and carbapenems. The firm develops products for the prevention of antibiotic resistance, antibiotic-associated diarrhea and hospital associated infections. The company was founded in 2000 and is headquartered in Helsinki, Finland. | Directeur/Bestuurslid | - |
Opleiding van Riitta Jääskeläinen
University of Helsinki | Graduate Degree |
Aalto University School of Science & Technology | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Ipsat Therapies Oy
![]() Ipsat Therapies Oy Pharmaceuticals: MajorHealth Technology Ipsat Therapies Oy develops and manufactures antibiotics & drugs. Its products include penicillins, cephalosporins and carbapenems. The firm develops products for the prevention of antibiotic resistance, antibiotic-associated diarrhea and hospital associated infections. The company was founded in 2000 and is headquartered in Helsinki, Finland. | Health Technology |
Suomen Teollisuussijoitus Oy
![]() Suomen Teollisuussijoitus Oy Investment ManagersFinance Suomen Teollisuussijoitus Oy (Suomen Teollisuussijoitus) is a private equity and venture capital subsidiary of Government of Finland founded in 1995. The firm is headquartered in Helsinki, Finland. | Finance |